Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04602533
Title Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Michael Hopp
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Klinik Löwenstein gGmbH RECRUITING Löwenstein Baden-Würtemberg 74245 Germany Details
Klinikverbund Allgäu gGmbH RECRUITING Immenstadt Bayern 87509 Germany Details
Universitätsklinikum Gießen Marburg RECRUITING Gießen Hessen 35392 Germany Details
Klinikum Kassel GmbH-Klinik für Onkologie und Hämatologie RECRUITING Kassel Hessen 34125 Germany Details
Sana-Klinikum Offenbach RECRUITING Offenbach Hessen 63069 Germany Details
KEM GmbH RECRUITING Essen NRW 45136 Germany Details
Lungenklinik Hemer RECRUITING Hemer NRW D 58675 Germany Details
Universitätsklinikum Aachen RECRUITING Aachen 52074 Germany Details
Asklepios Klinikum Hamburg RECRUITING Hamburg 21075 Germany Details
Lungenklinik Köln-Merheim RECRUITING Köln 51109 Germany Details
Johannes Wesling Klinikum Minden RECRUITING Minden 32429 Germany Details
Asklepios Fachkliniken Muenchen Gauting RECRUITING München Gauting 82131 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field